These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 32372673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy, safety, and pharmacokinetics of sustained-release lanreotide (lanreotide Autogel) in Japanese patients with acromegaly or pituitary gigantism.
    Shimatsu A, Teramoto A, Hizuka N, Kitai K, Ramis J, Chihara K.
    Endocr J; 2013; 60(5):651-63. PubMed ID: 23337477
    [Abstract] [Full Text] [Related]

  • 4. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
    Bondanelli M, Bonadonna S, Ambrosio MR, Doga M, Gola M, Onofri A, Zatelli MC, Giustina A, degli Uberti EC.
    Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pituitary gigantism: Causes and clinical characteristics.
    Rostomyan L, Daly AF, Beckers A.
    Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
    [Abstract] [Full Text] [Related]

  • 8. Genetics of gigantism and acromegaly.
    Hannah-Shmouni F, Trivellin G, Stratakis CA.
    Growth Horm IGF Res; 2016 Dec; 30-31():37-41. PubMed ID: 27657986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
    Gheorghiu ML, Găloiu S, Vintilă M, Purice M, Hortopan D, Dumitraşcu A, Coculescu M, Poiană C.
    Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
    [Abstract] [Full Text] [Related]

  • 19. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I.
    Miyazaki R, Yoshida T, Sakane N, Yasuda T, Umekawa T, Kondo M, Shimatsu A, Hizuka N, Sano T.
    Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.